期刊文献+

胰腺导管腺癌根治性切除术后复发转移及预后影响因素分析 被引量:1

Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarctnoma
原文传递
导出
摘要 目的探讨胰腺导管腺癌根治性切除术后复发转移及预后的影响因素。方法回顾性分析56例胰腺导管腺癌根治性切除术患者的临床病理及随访资料,对患者术后复发转移及预后的影响因素进行单因素和多因素分析。结果56例胰腺导管腺癌患者根治性切除术后复发转移率为73.2%(41/56),术后3个月、6个月、1年和2年复发转移率分别为26.8%(15/56)、51.8%(29/56)、64.3%(36/56)和69.6%(39/56)。局部复发13例,肝转移15例,多脏器转移10例。病程、腰背痛症状、术前CA19-9水平、肿瘤大小、T分期、AJCC分期与胰腺导管腺癌术后复发转移有关(P〈0.05)。患者3年累积生存率为22.7%。单因素分析结果显示,T分期、CA19-9水平和肿瘤大小与胰腺导管腺癌患者的预后有关(P〈0.05)。多因素Cox回归分析结果显示,肿瘤大小是胰腺癌患者预后的独立影响因素(OR=2.08,95%凹为1.28~4.03)。结论胰腺导管腺癌多在术后2年内发生复发转移,肝脏是最常见的转移部位。病程、腰背痛、CA19-9、肿瘤大小、AJCC分期和T分期与术后复发转移有关,肿瘤大小是患者预后的独立影响因素。 Objective To investigate the factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma and analyze the prognosis. Methods The clinicopathological and follow-up data of 56 patients who underwent curative resection for pancreatic ductal adenocarcinoma between Jan. 1997 and Dec. 2006 in this hospital were analyzed retrospectively. Results The recurrence rate after curative resection was 73.2% (41/56). The recurrence rate after operation at the time of 3 months, half year, 1 year and 2 years was 26.8% (15/56), 51.8% (29/56), 64.3% (36/56) and 69.6% (39/56), respectively. Hepatic metastasis and local recurrence accounted for 36.6% and 31.7% of the cases, respectively. The 3-year accumulated survival of this group was 22. 7%. The symptom presenting time, back pain, preoprative level of CA19-9, tumor size, AJCC stage and T stage were correlated with metastasis/recurrence. Univariate analysis revealed that the preoprative level of CA19-9, T stage and the tumor size were prognostic factors. Cox regression analysis revealed that only tumor size was an independent prognostic factor. Conclusion The metastasis or recurrence mostly occurs within 2 years after curative resection, and the liver is the most common site of metastasis. High recurrence rate is the major reason causing the failure of curative resection and short survival time after operation. The symptom presenting time, back pain, preoperative level of CA19-9, tumor size, AJCC stage and T stage are correlated with metastasis/recurrence. The tumor size is an independent prognostic factor.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2008年第9期686-689,共4页 Chinese Journal of Oncology
关键词 胰腺肿瘤 肿瘤复发 肿瘤转移 预后 Pancreatic neoplasms Tumor metastasis Tumor recurrence Prognosis
  • 相关文献

参考文献12

  • 1Ozaki H, Hiraoka T, Mizumoto R, et al. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today, 1999, 29: 16-22. 被引量:1
  • 2Tsiotos GG, Famell MB, Sarr MG. Are the results of pancreatectomy for pancreatic cancer improving? World J Surg, 1999, 23:913- 919. 被引量:1
  • 3刘骞,赵平,王成峰,蔡建强,邵永孚,白晓枫.胰体尾癌外科治疗117例临床分析[J].中华外科杂志,2006,44(5):333-335. 被引量:24
  • 4吴健雄,邵永孚,荣维淇,单毅,高纪东,吴铁成.178例胰头癌的诊治分析[J].中华肿瘤杂志,2002,24(5):497-500. 被引量:20
  • 5Han SS, Jang JY, Kim SW, et al. Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas, 2006, 32 : 271-275. 被引量:1
  • 6Sperti C, Pasquali C, Piccoli A, et al. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg, 1997, 21:195-200. 被引量:1
  • 7Nagakawa T, Sanada H, Inagaki M, et al. Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J Hepatobiliary Pancreat Surg, 2004, 11:402-408. 被引量:1
  • 8潘宏,王天翔.胰腺癌神经组织浸润的研究状况及临床意义[J].外科理论与实践,2004,9(1):81-83. 被引量:4
  • 9Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreatieoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg, 2006, 10 : 1199-1211. 被引量:1
  • 10Takamori H, Hiraoka T, Kanemitsu K, et al. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer: under-analysis of cumulative survival curve. World J Surg, 2006, 30:213-218. 被引量:1

二级参考文献24

  • 1杨维良,张新晨,佟伯峰.胰体尾部癌222例诊治报告[J].中华肝胆外科杂志,2004,10(8):520-522. 被引量:17
  • 2钟守先.积极开展胰头癌根治术——为提高五年生存率而努力[J].中华肝胆外科杂志,1998,4(5):267-268. 被引量:14
  • 3刘骞,邵永孚,王成峰,赵平.保留脾脏的胰体尾癌切除14例分析[J].中华肝胆外科杂志,2005,11(4):248-249. 被引量:22
  • 4Birgir Gudjonsson. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. Am Coll Surg, 1995, 181:483-503. 被引量:1
  • 5Adsay NV, Conlon KC, Zee SY, et al. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer, 2002, 94:62-77. 被引量:1
  • 6Bluemke DA, Cameron JL, Hruban RH. Potentially respectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology, 1995, 197:381-385. 被引量:1
  • 7Banfi G, Zerbi A, Pastori S, et al. Behavior of tumor markers. CA19-9, CA195, CAM43, CA242, and TPS in the diagnosis and follow-up of pancreatic cancer. Clin Chem, 1993, 39: 420-423. 被引量:1
  • 8Tian F, Appert HE, Myles J, et al. Prognostic value of serum CA19-9 levels in pancreatic adenocarcinoma. Ann Surg, 1992, 215: 350-355. 被引量:1
  • 9Paulino AC, Latona C. Unresectable adenocarcinoma of the pancreas: patterns of failure and treatment results. Cancer Invest, 2000, 18: 309-313. 被引量:1
  • 10Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas- 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg, 2000, 4: 567-579. 被引量:1

共引文献45

同被引文献20

  • 1王丽,杨功焕,李辉,陆星华.1991-2000年中国胰腺癌病死率的变迁[J].中华内科杂志,2005,44(7):509-513. 被引量:39
  • 2Ouyang H, Wang P, Meng Z, et al. Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine]J]. Pancreas, 2011, 40( 1) : 120-125. 被引量:1
  • 3Paulson AS, Tran Cao HS, Tempero MA, et al. Therapeutic advances in pancreatic cancer[J]. Gastroenterology, 2013,144(6) :1316- 1326. 被引量:1
  • 4Levi Z, KarkJD, Afek A, et al. Measured body mass index in adolescence and the incidence of pancreatic cancer in a cohort of 720,000Jewish men[J]. Cancer Causes Control, 2012, 23 ( 2) : 371-378. 被引量:1
  • 5Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms[J]. Mol Carcinog, 2012, 51 (1) :53-63. 被引量:1
  • 6Li D, MorrisJ5, LiuJ, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer] n.JAMA, 2009, 301 (24) : 2553-2562. 被引量:1
  • 7Fujioka 5, Misawa T, Okamoto T, et al. Predictors for postoperative liver metastasis in patients with resectable pancreatic cancer]J J. Int Surg , 2008, 93(6) :324-330. 被引量:1
  • 8Matsumoto G, Muta M, Tsuruta K, et al. Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer[J]. Pancreatology, 2007, 7(2-3) : 167-173. 被引量:1
  • 9Tani M, Kawai M, Miyazawa M, et al. Liver metastasis as an initial recurrence has no impact on the survival of patients witb resectable pancreatic adenocarcinoma[J]. Langenbecks Arch Surg, 2009, 394(2) :249-253. 被引量:1
  • 10FolkmanJ ITole of angiogenesis in tumor growth and metastasis[J]. Semin Oncol, 2002, 29(6 Suppl16) :15-18. 被引量:1

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部